Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush NSCLC Subject Treatment Study
Clinical Trial Protocol ID
12092604

Clinical Trial Investigator Name
Mary Jo Fidler

Clinical Trial Title

A Phase II/III Randomized Trial of Two Doses of MK-3475 versus Docetaxel in Previously Treated Subjects with NSCLC



Clinical Trial Protocol Description

Treatment of subjects with NSCLC whose tumors are positive for PD-L1 and have experienced disease progression after a platinum-containing systemic treatment. The purpose of this study is to test the safety and tolerability of the research study drug MK-3475 and to test the effectiveness of the study drug to standard care Docetaxel. Nationwide, 520 to 920 patients will be recruited for this study. At Rush University Medical Center, we expect to recruit approximately 10 patients.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Have stage IIIb or IV NSCLC with positive PD-L1
  • Have progressed with platinum-containing treatment
  • Must know or have tissue tested for EGFR and ALK mutation. If EGFR+ - must have also been on a EGFR tyrosine kinase inhibitor. If ALK+ - must have been on crizotinib

You will be excluded from this study if you:

  • Have received prior treatment with Docetaxel for NSCLC
  • Have had a previous malignancy within the past five years (exception — basal cell carcinoma, squamous cell carcinoma of the skin, superficial bladder cancer or in situ cervical cancer)
  • Have active or a history of autoimmune disease
  • Have a history of organ transplant
  • Are pregnant or lactating

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.





Contact Name Andrea Glidden
Contact Phone (312) 942-2364
Promotional Information

Clinical Trials Home
Cancer Clinical Trials
NSCLC Subject Treatment Study

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois